Results from Eli Lilly's Phase III study for the GLP-1 are being presented at the ADA's 85th Scientific Sessions in June and additionally published in a journal
Sometimes during shortages, medications were switched to alternatives. People may experience side effects or switch medication Another reason could be that patients didnt fully stop treatment but switched to a different medication for weight loss
What works for one persons body may not be right for another, especially when factors like blood donation, activity levels, and underlying health conditions are involved
We can modify or cancel an order only if it hasnt been processed or shipped
research on gut microbiome-metabolism connections continues advancing, potentially identifying additional beneficial strains or optimal formulation strategies
4-5 When it comes to using GLP-1 medications in teens, risk versus benefit needs to be weighed in a thoughtful, individualized way